ES2199687A1 - Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium. - Google Patents

Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.

Info

Publication number
ES2199687A1
ES2199687A1 ES200201853A ES200201853A ES2199687A1 ES 2199687 A1 ES2199687 A1 ES 2199687A1 ES 200201853 A ES200201853 A ES 200201853A ES 200201853 A ES200201853 A ES 200201853A ES 2199687 A1 ES2199687 A1 ES 2199687A1
Authority
ES
Spain
Prior art keywords
cyclodextrin
beta
treatment
cas
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES200201853A
Other languages
English (en)
Inventor
Mazas Maria Elvira Ares
Hermida Jose Antonio Castro
Mendez Jose Blanco
Espinar Francisco J Otero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES200201853A priority Critical patent/ES2199687A1/es
Priority to PCT/ES2003/000410 priority patent/WO2004014289A2/es
Publication of ES2199687A1 publication Critical patent/ES2199687A1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Utilización de la {be}-ciclodextrina (CAS RN: 7585-39-9), en la preparación de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parásitos pertenecientes al género Cryptosporidium. Administrada por vía oral, sola o formando complejos de inclusión como agente profiláctico y/o terapéutico en el tratamiento de la cryptosporidiosis animal. La {be}-ciclodextrina y sus complejos pueden administrarse como tales o incluirse en el agua de bebida y mezclados con el pienso, utilizando para ello diversas formulaciones que faciliten su administración; y pueden emplearse para favorecer la eliminación de las formas infectantes de Cryptosporidium (los ooquistes) existentes en aguas residuales y purines.
ES200201853A 2002-08-05 2002-08-05 Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium. Pending ES2199687A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200201853A ES2199687A1 (es) 2002-08-05 2002-08-05 Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.
PCT/ES2003/000410 WO2004014289A2 (es) 2002-08-05 2003-08-05 UTILIZACIÓN DE LA beta-CICLODEXTRINA (CAS RN: 7585-39-9) EN LA PREPARACIÓN DE MEDICAMENTOS PARA EL TRATAMIENTO DE LAS ENFERMEDADES HUMANAS O ANIMALES CAUSADAS POR PARÁSITOS PERTENECIENTES AL GÉNERO CRYPTOSPORIDIUM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201853A ES2199687A1 (es) 2002-08-05 2002-08-05 Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.

Publications (1)

Publication Number Publication Date
ES2199687A1 true ES2199687A1 (es) 2004-02-16

Family

ID=31502890

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201853A Pending ES2199687A1 (es) 2002-08-05 2002-08-05 Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.

Country Status (2)

Country Link
ES (1) ES2199687A1 (es)
WO (1) WO2004014289A2 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005138A1 (en) * 2000-07-06 2002-01-17 Lawrence Mark H Process guru
WO2002069949A2 (en) * 2001-03-06 2002-09-12 Prendergast Patrick T Combination therapy for reduction of toxycity of chemotherapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005138A1 (en) * 2000-07-06 2002-01-17 Lawrence Mark H Process guru
WO2002069949A2 (en) * 2001-03-06 2002-09-12 Prendergast Patrick T Combination therapy for reduction of toxycity of chemotherapeutic agents

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
J.A. CASTRO-HERMIDA; F. FREIRE-SANTOS; M. GONZALEZ-WARLETA; M. MEZO-MENENDEZ; E. ARES-MAZAS. Efficacy of Beta-cyclodextrin against experimental Cryptosporidiosis in neonatal lambs. Journal Parasitology 2002, Vol. 88 (1), paginas 185-187. *
J.A. CASTRO-HERMIDA; J. QUILEZ-CINCA; F. LOPEZ-BERNAD; C. SANCHEZ-ACEDO; F. FREIRE-SANTOS; E. ARES-MAZAS. Treatment with Beta-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions. International Journal for Parasitology 2001, Vol. 31 (10), paginas 1134-1137. *
J.A. CASTRO-HERMIDA; YOLANDA GONZALEZ-LOSADA; FRANCISCO FREIRE-SANTOS; MERCEDES MEZO-MENENDEZ; ELVIRA ARES-MAZAS. Evaluation of Beta-cyclodextrin against natural infections of cryptoporidiosis in calves. Veterinary Parasitology 2001, Vol. 101 (2), paginas 85-89. *
L. NIETO-REYES; M.E. VILLAR LOPEZ; J.A. CASTRO HERMIDA; E. ARES-MAZAS; F. OTERO ESPINAR; J. BLANCO-MENDEZ. Inclusion study in Beta-cyclodextrin and dimetil-Beta-cyclodextrin of antiparasitaries in solution and the solid state. Proceedings of the International Symposium on Cyclodextrins, 9th, Santiago de Compostela, Spain, Mayo 31- Junio 3, 1998 (1999) Meeting Date 1998, paginas 411-414. *
ROSANE MARIA BUDAL; JACIR DAL MAGRO; INES MARIA COSTA BRIGHENTE; JOSE VAZQUEZ TATO; ROSENDO AUGUSTO YUNES. Estudio comparativo entre as constantes de associaçao do fuorato de diloxanida com Beta-ciclodextrina e Beta-ciclodextrina sulfatada. [en linea], 25.04.2002 [recuperado el 01.12.2003]. Recuperado de Internet: <URL:http://www.sbq.org.br/ranteriores/23/resumos/0273/>. *
Utilizacion de los complejos de inclusion con ciclodextrinas para mejorar la eficacia de algunos antiparasitarios. [en linea], 19.02.2001 [recuperado el 28.10.2003]. Recuperado de Internet: <URL:http://www.usc.es/spubl/nieto_e.htm>. *

Also Published As

Publication number Publication date
WO2004014289A3 (es) 2004-03-18
WO2004014289A2 (es) 2004-02-19

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
BRPI0516024A (pt) uso de azd 2171 ou de um sal farmaceuticamente aceitável do mesmo e de imatinib, composição farmacêutica, kit, e, método para a produção de um efeito antiangiogênico e/ou de redução da permeabilidade vascular em um animal de sangue quente
CN1627951A (zh) 用以预防及治疗口疮溃疡与单纯疱疹性损害的组成物及方法
TW200510392A (en) Chemical compounds
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
EP1830191A3 (en) Pharmaceutical preparations containing thiazolidinediones for the treatment of endocrine autoimmune diseases
HK1068606A1 (en) Novel aminobenzoephenones
TW200505452A (en) Chemical compounds
GB2456475A (en) Composition for the treatment of skin conditions
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
EP1780212A4 (en) DERIVATIVE OF PYRAZOLO [1,5-a] PYRIMIDINE
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
ES2199687A1 (es) Utilizacion de la beta-ciclodextrina en la preparacion de medicamentos para el tratamiento de las enfermedades humanas o animales causadas por parasitos pertenecientes al genero cryptosporidium.
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
SI1853308T1 (sl) Farmacevtski pripravek za zdravljenje rib ki se ga lahko administrira oralno postopek priprave navedenega pripravka in uporaba le tega
HUP0301451A2 (hu) CGMP PDE5 inhibitorok alkalmazása perifériás érbetegségek, perifériás neuropátiák és autonóm neuropátiák kezelésére szolgáló gyógyszerkészítmények elżállítására
NZ538926A (en) Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
WO2008079818A3 (en) Intravenous administration of water soluble analgesic formulations

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040216

Kind code of ref document: A1

FC2A Grant refused

Effective date: 20050216